Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on July 30, 2026

Jul. 30, 2026

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

Indeterminate GlobeNewswire

Jul. 30, 2026

PharmAla Issues Q3 Financial Statements and AGM Update

Indeterminate GlobeNewswire

Jul. 30, 2026

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Mobilicom Secures New Design Win for AI-Enabled Autonomous Weapon Systems

Indeterminate GlobeNewswire

Jul. 30, 2026

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

Indeterminate GlobeNewswire

Jul. 30, 2026

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Gilat to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jul. 30, 2026

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Allegro MicroSystems Reports First Quarter 2027 Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Soulloop Acquires Astrolumi.AI to Bring Astrologer-Led Daily Practice to WhatsApp

Indeterminate GlobeNewswire

Jul. 30, 2026

Why Autonomous Surface Finishing Works Across Industries

Indeterminate GlobeNewswire

Jul. 30, 2026

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

Indeterminate GlobeNewswire

Jul. 30, 2026

Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Jul. 30, 2026

illumin and Audience Acuity partner to shape the future of audience intelligence

Indeterminate GlobeNewswire

Jul. 30, 2026

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

Jul. 30, 2026

HII Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Jul. 30, 2026

FLYR Hospitality Named Preferred Revenue Management System and Business Intelligence Vendor for Global Hotel Alliance

Indeterminate GlobeNewswire

Jul. 30, 2026

Xtract One Technologies Expands California Healthcare Footprint With Multiple Deployments Across the State

Indeterminate GlobeNewswire